World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon
World Vaccine Congress Europe 2026 Exhibitors
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
145 organizations exhibit at World Vaccine Congress Europe 2026, led by suppliers and service providers. 87 of them also present on the scientific program, with 103 presentations between them. Most represented: African Field Epidemiology Network (AFENET), Tonix Pharmaceuticals and Abera Bioscience. As of Oct 12, 2026.
All 268 organizations at World Vaccine Congress Europe 2026 →
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
African Field Epidemiology Network (AFENET) Kampala, Uganda | |
Non-profit network that trains field epidemiologists and supports disease surveillance, outbreak response and immunization programs across Africa. | Booth Exhibiting (no floor booth listed) Talk Mon Oct 19 15:45 Talk Tue Oct 20 11:30 |
Tonix Pharmaceuticals Chatham, NJ | |
Biopharmaceutical company whose vaccine work includes TNX-801, a horsepox-based vaccine platform. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 11:30 Working Group: Vectored Vaccine Platforms: from design to improving efficacy Platforms & delivery Talk Wed Oct 21 13:15 |
Develops mucosal vaccines against serious infectious diseases on a proprietary platform of outer membrane vesicles (OMVs). | Booth Exhibiting (no floor booth listed) Talk Mon Oct 19 10:30 Talk Wed Oct 21 10:30 From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials. |
Japanese vaccine maker linked to Osaka University, producing influenza and other vaccines. | Booth Exhibiting at Booth 226 Talk Tue Oct 20 14:30 |
Uses its AI-Immunology platform to discover and design vaccines against bacterial and viral infections and cancer. | Booth Exhibiting at Booth 216 Talk Wed Oct 21 11:00 Talk Wed Oct 21 11:30 |
Laboratory services for drug discovery and development, including central laboratory and specialty biomarker services. | Booth Exhibiting at Booth 410 Talk Tue Oct 20 14:00 |
Drug delivery partner supplying delivery devices, formulation and development services, including nasal delivery, to pharmaceutical companies worldwide. | Booth Exhibiting (no floor booth listed) |
AI-native participant relationship management platform that brings clinical research sites' trial recruitment workflows into one system. | Booth Exhibiting at Booth SU11 Talk Wed Oct 21 11:10 Keeping Recruitment Moving in Vaccine Trials Clinical & preclinical development |
Belgian medical device company making delivery devices, including the VAX-ID intradermal system, for prophylactic, diagnostic and therapeutic use. | Booth Exhibiting at Booth SU27 Talk Tue Oct 20 12:45 |
Global management consulting firm. | Booth Exhibiting (no floor booth listed) Talk Wed Oct 21 12:45 Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster. |
Develops bacteriophage treatments, viruses that kill bacteria, as an answer to antibiotic resistance, starting with cholera. | Booth Exhibiting at Booth SU4 Talk Tue Oct 20 12:50 Start-up Pitch 3: PhagePro Infectious disease & AMR |
Thermo Fisher Scientific’s clinical research business, serving drug and vaccine developers across early development, clinical trials and commercial manufacturing. | Booth Exhibiting (no floor booth listed) |
Vaxxirna Houston, TX | |
Develops circular RNA vaccines for infectious diseases, with heat-stable lipid nanoparticle formulations and microneedle patch delivery. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 16:00 Safe and Efficacious Circular RNA Vaccines to Treat Yellow Fever and Dengue Infectious disease & AMRPlatforms & delivery |
UK Health Security Agency (UKHSA) London, UK | |
UK agency that plans for, prevents and responds to health threats, providing scientific and operational leadership nationally and globally. | Booth Exhibiting at Booth 417 Talk Mon Oct 19 16:15 Panel: From Early Signals to Decisions: The Future of Outbreak Intelligence How genome sequencing, wastewater testing and health records can flag outbreaks early enough to guide vaccine strain choice and policy. Panel Wed Oct 21 10:45 Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain. Talk Wed Oct 21 13:20 Panel Wed Oct 21 13:30 Panel: Controlled Human Infection Models (CHIMs): Evidence, Ethics and the Next Phase of Vaccine R&D How studies that deliberately infect volunteers guide vaccine decisions, and what must be in place before using them for new diseases. |
HL Hilleman Laboratories Singapore, Singapore | |
Vaccine research and development organization, founded by MSD and Wellcome, developing affordable vaccines for low- and middle-income countries. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 11:30 Working Group: Partnerships for Prevention: Accelerating Vaccines to Curb Antimicrobial Resistance How partnerships across sectors could speed up and widen access to vaccines against drug-resistant bacteria, such as a maternal Klebsiella vaccine for newborns. Infectious disease & AMRSupply, safety & access Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing Talk Wed Oct 21 12:15 Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need. |
Contract research organization for infectious disease and zoonoses research, offering bioanalytical services and preclinical studies; part of GD Group. | Booth Exhibiting at Booth 413 Talk Tue Oct 20 16:15 |
Croda Pharma Snaith, United Kingdom | |
Supplies adjuvant systems, lipids for nucleic acid delivery and high-purity excipients for vaccine and drug formulation. | Booth Exhibiting at Booth 214 Talk Tue Oct 20 14:00 Talk Tue Oct 20 16:00 Panel: Expanding the Access & Impact of Adjuvants How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries. |
Novavax Gaithersburg, MD | |
Vaccine company developing protein-based vaccines with its Matrix-M adjuvant, including a marketed COVID-19 vaccine. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 14:00 |
Supplies pharmaceutical excipients and vaccine adjuvants. | Booth Exhibiting at Booth 311 Talk Tue Oct 20 16:00 Panel: Expanding the Access & Impact of Adjuvants How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries. Talk Wed Oct 21 10:45 |
Vaccine-focused contract research organization, formerly FHI Clinical, offering research, development and partnering services to vaccine makers. | Booth Exhibiting at Booth 237 Panel Mon Oct 19 12:15 Panel: Chronic Conditions and Off-target Effects of Vaccines Whether vaccines like those for tuberculosis, measles and shingles affect unrelated infections, asthma or dementia, and how trials could measure it. Talk Wed Oct 21 14:15 |
Acuitas Therapeutics Vancouver, Canada | |
Develops lipid nanoparticle (LNP) delivery systems for mRNA vaccines and therapeutics, licensed to partner companies. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 14:15 |
Clinical-stage biotech whose capsid virus-like particle (cVLP) display platform builds vaccines, including a COVID-19 vaccine program. | Booth Exhibiting (no floor booth listed) |
Alcimed Paris, France | |
Innovation and new-business consulting firm helping life sciences clients explore and develop new markets and products. | Booth Exhibiting (no floor booth listed) Talk Wed Oct 21 13:45 |
Specialises in quantifying HLA-presented peptides, with liquid biopsy and AI platforms supporting safer, more effective immunotherapies. | Booth Exhibiting at Booth 553 |
CDMO offering one-stop development and manufacturing of mRNA vaccines and therapeutics, with research support from group company Axcelead DDP. | Booth Exhibiting at Booth 422 Talk Tue Oct 20 16:00 |
Start-up developing glycoconjugate vaccines against bacterial infections, led by a program to prevent urinary tract and invasive E. coli infections. | Booth Exhibiting at Booth SU31 Talk Tue Oct 20 13:15 |
Biological E Hyderabad, India | |
Indian vaccine and pharmaceutical manufacturer supplying vaccines to low- and middle-income countries. | Booth Exhibiting at Booth 307 Talk Mon Oct 19 10:45 |
Biomedical Primate Research Centre (BPRC) Rijswijk, Netherlands | |
Research institute running non-human primate studies of infectious and other diseases, including preclinical vaccine research. | Booth Exhibiting (no floor booth listed) |
Insud Pharma Group drug delivery company using electronebulization and electrospinning to make fiber or powder formulations with tailored drug release. | Booth Exhibiting at Booth 425 Talk Tue Oct 20 14:15 |
Develops supercritical CO2 processes, offering feasibility studies, scale-up, licensing and production, including continuous manufacturing of nanocarriers. | Booth Exhibiting at Booth SU3 Talk Wed Oct 21 11:30 Redefining Nanocarrier Manufacturing with Scalable Continuous scCO₂ Processing for Advanced Vaccine Delivery Bioprocess & manufacturingPlatforms & delivery |
Find buyers from World Vaccine Congress Europe 2026 exhibitors
Tell us what you sell and we’ll find the people at these exhibitors most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse World Vaccine Congress Europe 2026 by
- Exhibitors 145
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction